The Global Triflusal Market was valued at USD 42.7 million in 2024 and is projected to reach USD 59.1 million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period (2024-2030). This growth is driven by increasing prevalence of cardiovascular diseases and triflusal’s advantages over traditional antiplatelet therapies with fewer gastrointestinal side effects.

As global pharmaceutical standards become more stringent, the triflusal market is defined by API manufacturers and research chemical suppliers with strong regulatory compliance. This report profiles the Top 10 Companies in the Triflusal Industry – from established pharma players to specialized chemical producers enabling critical cardiovascular treatments worldwide.

---

🔟 1. HBCChem

Headquarters: San Francisco, California, USA
Key Offering: Triflusal API (CAS 322-79-2) in research and GMP grades

HBCChem has emerged as a reliable supplier of high-purity triflusal active pharmaceutical ingredient (API) with batch-to-batch consistency. Their California facility serves pharmaceutical manufacturers and research institutions globally with small-to-medium volume production capabilities.

Technical Capabilities:

• ISO 9001:2015 and GMP compliant manufacturing
• Custom synthesis from grams to kilograms
• Full analytical characterization including HPLC, NMR and MS

Download FREE Sample Report:
Global Triflusal Market – View in Detailed Research Report

---

9️⃣ 2. Alfa Chemistry

Headquarters: New York, USA
Key Offering: Triflusal reference standards and bulk quantities

Alfa Chemistry provides pharmaceutical-grade triflusal with purity levels ranging from 98% to 99.9% for formulation development and clinical research applications. Their global distribution network ensures reliable supply to customers worldwide.

Technical Capabilities:

• GMP-certified manufacturing partners
• Stability testing and method validation services
• Custom packaging solutions available

---

8️⃣ 3. BOC Sciences

Headquarters: Shirley, New York, USA
Key Offering: Custom triflusal API manufacturing

BOC Sciences offers triflusal production from contract research quantities to commercial scale, with specialized expertise in process optimization and impurity profiling. Their FDA-inspected facilities serve leading pharmaceutical companies.

Technical Capabilities:

• ICH Q7 compliant manufacturing
• Patented crystallization technology
• Regulatory documentation support

---

7️⃣ 4. Toronto Research Chemicals

Headquarters: Toronto, Canada
Key Offering: High-purity triflusal analytical standards

TRC produces certified reference materials for triflusal with comprehensive characterization data, serving analytical laboratories and quality control departments in pharmaceutical companies globally.

Technical Capabilities:

• ISO/IEC 17025 accredited laboratory
• USP/EP monograph compliance
• Stability-indicating methods

Download FREE Sample Report:
Global Triflusal Market – View in Detailed Research Report

---

6️⃣ 5. Dalton Chemical Laboratories

Headquarters: Toronto, Canada
Key Offering: GMP-grade triflusal API

Dalton provides triflusal manufactured under current Good Manufacturing Practices with complete regulatory packages including method validation reports and stability data.

Technical Capabilities:

• Health Canada approved facility
• EDMF/DMF documentation available
• Particle size engineering services

---

5️⃣ 6. 3B Scientific

Headquarters: Hong Kong, China
Key Offering: Research-grade triflusal

3B Scientific supplies triflusal for pharmacological research and drug discovery applications, with particular focus on serving academic institutions and biotechnology companies.

Technical Capabilities:

• ISO certified quality management
• Custom synthesis services
• Technical datasheets with full characterization

---

4️⃣ 7. AlliChem

Headquarters: Blacksburg, Virginia, USA
Key Offering: Pharmaceutical intermediates and API

AlliChem manufactures triflusal in its FDA-registered facility with capabilities ranging from laboratory-scale development to pilot plant production (1-50kg batches).

Technical Capabilities:

• Current Drug Master File
• Process development services
• Impurity identification and control

---

3️⃣ 8. Ivy Fine Chemicals

Headquarters: Cherry Hill, New Jersey, USA
Key Offering: cGMP triflusal API

Ivy Fine Chemicals specializes in the production of triflusal under current Good Manufacturing Practices, supplying pharmaceutical companies with technically demanding API requirements.

Technical Capabilities:

• FDA-inspected manufacturing
• EU GMP compliance
• Pilot scale to commercial production

---

2️⃣ 9. Waterstone Technology

Headquarters: Carmel, Indiana, USA
Key Offering: High-purity triflusal for research

Waterstone Technology provides triflusal for pharmaceutical research and formulation development, with comprehensive analytical data packages and batch documentation.

Technical Capabilities:

• ISO 9001 certified quality system
• Stability study support
• Custom purity specifications

---

1️⃣ 10. Hefei Topway Biotechnology

Headquarters: Hefei, China
Key Offering: Cost-competitive triflusal API

As a leading Chinese API manufacturer, Hefei Topway offers triflusal manufactured in facilities meeting international quality standards at competitive pricing.

Technical Capabilities:

• GMP certified production
• CEPs and DMFs available
• Scaled-up manufacturing capacity

Get Full Report Here:
Global Triflusal Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Cardiovascular APIs

The triflusal market reflects broader trends in cardiovascular drug development, with increasing emphasis on quality, consistency and regulatory compliance across global supply chains.

📈 Key Market Trends:

• Growing generic API production in regulated markets
• Increasing regulatory scrutiny of impurity profiles
• Adoption of continuous manufacturing technologies
• Expansion of GMP-certified production in Asia

Get Full Report Here:
Global Triflusal Market – View in Detailed Research Report

The companies profiled above represent the global infrastructure delivering this essential cardiovascular therapy to patients while meeting the pharmaceutical industry’s most stringent quality standards.